John Nicholson, SVP & Chief Operating Officer at NEKTAR THERAPEUTICS (NKTR), sold 31,820 shares at $37.78 ($1.2M) on 2017-11-13, disclosed to the SEC on 2017-11-15.
Open-market sale of $1.2M NKTR by SVP & Chief Operating Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $37.78 | 15,910 | $601K | 50.0% |
| 2 | $37.78 | 15,910 | $601K | 50.0% |
| Total | $37.78 avg | 31,820 | $1.2M | 100% |
| Filing → |
| NKTR | SELL | 2019-02-21 | $324K | — | Filing → |
| NKTR | SELL | 2019-01-30 | $2.7M | — | Filing → |
| NKTR | SELL | 2018-11-19 | $458K | — | Filing → |